Back

HFpEF management: state of the art SGLT2 inhibitors.

28 August 2021 (09:41 - 09:52)
Organised by:
Congress Presentation Part of: How-To manage HFpEF: state of the art in 2021 Chronic Heart Failure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
HFpEF management: state of the art neurohumoral modulation.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
HFpEF management: state of the art novel devices.
Professor D. Kaye (Melbourne, AU)
Slides Video
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 – discussion.
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Access the full session

Session thumbnail
How-To manage HFpEF: state of the art in 2021
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 09:41 CET
You may be interested in
thumbnail
Webinar
Management of heart failure with preserved ejection fraction. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
Congress Presentation
HFpEF management: state of the art neurohumoral modulation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources